Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 3
2012 4
2013 2
2014 3
2015 5
2016 4
2017 2
2018 1
2019 3
2020 2
2021 3
2022 2
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Origin and Pathogenesis of B Cell Lymphomas.
Seifert M, Scholtysik R, Küppers R. Seifert M, et al. Among authors: scholtysik r. Methods Mol Biol. 2019;1956:1-33. doi: 10.1007/978-1-4939-9151-8_1. Methods Mol Biol. 2019. PMID: 30779028 Review.
Origin and pathogenesis of B cell lymphomas.
Seifert M, Scholtysik R, Küppers R. Seifert M, et al. Among authors: scholtysik r. Methods Mol Biol. 2013;971:1-25. doi: 10.1007/978-1-62703-269-8_1. Methods Mol Biol. 2013. PMID: 23296955 Review.
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma.
Kadow S, Schumacher F, Kramer M, Hessler G, Scholtysik R, Oubari S, Johansson P, Hüttmann A, Reinhardt HC, Kleuser B, Zoratti M, Mattarei A, Szabò I, Gulbins E, Carpinteiro A. Kadow S, et al. Among authors: scholtysik r. Cancers (Basel). 2022 Apr 13;14(8):1955. doi: 10.3390/cancers14081955. Cancers (Basel). 2022. PMID: 35454865 Free PMC article.
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
Johansson P, Klein-Hitpass L, Choidas A, Habenberger P, Mahboubi B, Kim B, Bergmann A, Scholtysik R, Brauser M, Lollies A, Siebert R, Zenz T, Dührsen U, Küppers R, Dürig J. Johansson P, et al. Among authors: scholtysik r. Blood Cancer J. 2018 Jan 19;8(1):11. doi: 10.1038/s41408-017-0036-5. Blood Cancer J. 2018. PMID: 29352181 Free PMC article. Clinical Trial.
Genomic and epigenomic co-evolution in follicular lymphomas.
Loeffler M, Kreuz M, Haake A, Hasenclever D, Trautmann H, Arnold C, Winter K, Koch K, Klapper W, Scholtysik R, Rosolowski M, Hoffmann S, Ammerpohl O, Szczepanowski M, Herrmann D, Küppers R, Pott C, Siebert R; HaematoSys-Project. Loeffler M, et al. Among authors: scholtysik r. Leukemia. 2015 Feb;29(2):456-63. doi: 10.1038/leu.2014.209. Epub 2014 Jul 16. Leukemia. 2015. PMID: 25027518
Post-ischemic protein restriction induces sustained neuroprotection, neurological recovery, brain remodeling, and gut microbiota rebalancing.
Silva de Carvalho T, Singh V, Mohamud Yusuf A, Wang J, Schultz Moreira AR, Sanchez-Mendoza EH, Sardari M, Nascentes Melo LM, Doeppner TR, Kehrmann J, Scholtysik R, Hitpass L, Gunzer M, Hermann DM. Silva de Carvalho T, et al. Among authors: scholtysik r. Brain Behav Immun. 2022 Feb;100:134-144. doi: 10.1016/j.bbi.2021.11.016. Epub 2021 Nov 27. Brain Behav Immun. 2022. PMID: 34848338 Free article.
Chemoproteomics Reveals the Pan-HER Kinase Inhibitor Neratinib To Target an Arabidopsis Epoxide Hydrolase Related to Phytohormone Signaling.
Ninck S, Halder V, Krahn JH, Beisser D, Resch S, Dodds I, Scholtysik R, Bormann J, Sewald L, Gupta MD, Heilmann G, Bhandari DD, Morimoto K, Buscaill P, Hause B, van der Hoorn RAL, Kaschani F, Kaiser M. Ninck S, et al. Among authors: scholtysik r. ACS Chem Biol. 2023 May 19;18(5):1076-1088. doi: 10.1021/acschembio.2c00322. Epub 2023 Apr 28. ACS Chem Biol. 2023. PMID: 37115018
p53 protein expression in chronic lymphocytic leukemia.
Sellmann L, Carpinteiro A, Nückel H, Scholtysik R, Siemer D, Klein-Hipass L, Kube D, Dürig J, Dührsen U, Stanelle J, Küppers R. Sellmann L, et al. Among authors: scholtysik r. Leuk Lymphoma. 2012 Jul;53(7):1282-8. doi: 10.3109/10428194.2011.654115. Epub 2012 Feb 13. Leuk Lymphoma. 2012. PMID: 22220854
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.
Johansson P, Bergmann A, Rahmann S, Wohlers I, Scholtysik R, Przekopowitz M, Seifert M, Tschurtschenthaler G, Webersinke G, Jäger U, Siebert R, Klein-Hitpass L, Dührsen U, Dürig J, Küppers R. Johansson P, et al. Among authors: scholtysik r. Int J Cancer. 2016 Jan 1;138(1):121-4. doi: 10.1002/ijc.29697. Epub 2015 Jul 30. Int J Cancer. 2016. PMID: 26199174
Gene dosage effects in chronic lymphocytic leukemia.
Sellmann L, Scholtysik R, Kreuz M, Cyrull S, Tiacci E, Stanelle J, Carpinteiro A, Nückel H, Boes T, Gesk S, Siebert R, Klein-Hitpass L, Dührsen U, Dürig J, Küppers R. Sellmann L, et al. Among authors: scholtysik r. Cancer Genet Cytogenet. 2010 Dec;203(2):149-60. doi: 10.1016/j.cancergencyto.2010.09.002. Cancer Genet Cytogenet. 2010. PMID: 21156227
29 results